Confirmation Made on Successive Rollout of Bioequivalence Testing Requirement

The Regulatory Reform Committee recently announced of the final recommendations generated from the extra deliberation session on the amendment proposals to the Korea Pharmaceutical Affairs Law.

Among the various draft amendments that were under review by the committee, the pharmaceutical industry has been giving a special attention on the compulsory bioequivalence testing requirement. In th...